Making the case for sacubitril/valsartan in patients with heart failure with a preserved ejection fraction

Eur Heart J Cardiovasc Pharmacother. 2021 May 23;7(3):e5-e6. doi: 10.1093/ehjcvp/pvab007.

Andrew Tai¹, Andrew P Ambrosy^{2

3}, Marat Fudim^{4

5}

¹ Department of Medicine, Kaiser Permanente San Francisco Medical Center, San Francisco, CA, USA.
² Department of Cardiology, Kaiser Permanente San Francisco Medical Center, San Francisco, CA, USA.
³ Division of Research, Kaiser Permanente Northern California, Oakland, CA, USA.
⁴ Division of Cardiology, Duke University Medical Center, 2301 Erwin Road, Durham, NC 27710, USA.
⁵ Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA.

No abstract available

Publication types